Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

BACKGROUND AND PURPOSE: The Meta-Analysis of Chemotherapy in squamous cell Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) improved overall survival (OS) in patients without distant metastasis. We report the updated results. MATERIALS AND METHODS: Published or unpublished randomized trials including patients with non-metastatic carcinoma randomized between 1965 and 2016 and comparing curative loco-regional treatment (LRT) to LRT + CT or adding another timing of CT to LRT + CT (main question), or comparing induction CT + radiotherapy to radiotherapy + concomitant (or alternating) CT (secondary question) were eligible. Individual patient data were collected and combined using a fixed-effect model. OS was the main endpoint. RESULTS: For the main question, 101 trials (18951 patients, median follow-up of 6.5 years) were analyzed. For both questions, there were 16 new (2767 patients) and 11 updated trials. Around 90% of the patients had stage III or IV disease. Interaction between treatment effect on OS and the timing of CT was significant (p < 0.0001), the benefit being limited to concomitant CT (HR: 0.83, 95%CI [0.79; 0.86]; 5(10)-year absolute benefit of 6.5% (3.6%)). Efficacy decreased as patients age increased (p_trend = 0.03). OS was not increased by the addition of induction (HR = 0.96 [0.90; 1.01]) or adjuvant CT (1.02 [0.92; 1.13]). Efficacy of induction CT decreased with poorer performance status (p_trend = 0.03). For the secondary question, eight trials (1214 patients) confirmed the superiority of concomitant CT on OS (HR = 0.84 [0.74; 0.95], p = 0.005). CONCLUSION: The update of MACH-NC confirms the benefit and superiority of the addition of concomitant CT for non-metastatic head and neck cancer

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

BACKGROUND: Former meta-analyses have shown a survival benefit for the addition of chemotherapy (CHX) to radiotherapy (RT) and to some extent also for the use of hyperfractionated radiation therapy (HFRT) and accelerated radiation therapy (AFRT) in locally advanced squamous cell carcinoma (SCC) of the head and neck. However, the publication of new studies and the fact that many older studies that were included in these former meta-analyses used obsolete radiation doses, CHX schedules or study designs prompted us to carry out a new analysis using strict inclusion criteria. METHODS: Randomised trials testing curatively intended RT (≥60 Gy in >4 weeks/>50 Gy in <4 weeks) on SCC of the oral cavity, oropharynx, hypopharynx, and larynx published as full paper or in abstract form between 1975 and 2003 were eligible. Trials comparing RT alone with concurrent or alternating chemoradiation (5-fluorouracil (5-FU), cisplatin, carboplatin, mitomycin C) were analyzed according to the employed radiation schedule and the used CHX regimen. Studies comparing conventionally fractionated radiotherapy (CFRT) with either HFRT or AFRT without CHX were separately examined. End point of the meta-analysis was overall survival. RESULTS: Thirty-two trials with a total of 10 225 patients were included into the meta-analysis. An overall survival benefit of 12.0 months was observed for the addition of simultaneous CHX to either CFRT or HFRT/AFRT (p < 0.001). Separate analyses by cytostatic drug indicate a prolongation of survival of 24.0 months, 16.8 months, 6.7 months, and 4.0 months, respectively, for the simultaneous administration of 5-FU, cisplatin-based, carboplatin-based, and mitomycin C-based CHX to RT (each p < 0.01). Whereas no significant gain in overall survival was observed for AFRT in comparison to CFRT, a substantial prolongation of median survival (14.2 months, p < 0.001) was seen for HFRT compared to CFRT (both without CHX). CONCLUSION: RT combined with simultaneous 5-FU, cisplatin, carboplatin, and mitomycin C as single drug or combinations of 5-FU with one of the other drugs results in a large survival advantage irrespective the employed radiation schedule. If radiation therapy is used as single modality, hyperfractionation leads to a significant improvement of overall survival. Accelerated radiation therapy alone, especially when given as split course radiation schedule or extremely accelerated treatments with decreased total dose, does not increase overall survival

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

We show the distribution of SARS-CoV-2 genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three available genomic nomenclature systems for SARS-CoV-2 to all sequence data from the WHO European Region available during the COVID-19 pandemic until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation. We provide a comparison of the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.Peer reviewe

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2

A scalable life cycle inventory of an electrical automotive traction machine—Part II: manufacturing processes

Purpose: A scalable life cycle inventory (LCI) model of a permanent magnet electrical machine, containing both design and production data, has been established. The purpose is to contribute with new and easy to use data for life cycle assessment (LCA) of electric vehicles by providing a scalable mass estimation and manufacturing inventory for a typical electrical automotive traction machine. The aim of this article (part II of two publications) is to present the manufacturing data with associated collection procedures, from material constituents to complete motor. Another objective is to explain the gate-to-gate system boundaries and the principles for linking the LCI model upstream, to database data, in order to create a full cradle-to-gate dataset. Methods: Data for design and production of electrical machines has been compiled from books, scientific papers, benchmarking literature, expert interviews, various specifications, factory records, and a factory site visit. For the manufacturing part, new primary data was collected directly from industry, with a motor factory and a steel mill in Sweden as main contributors, and from technical literature. Other LCA publications were used, if presented in sufficient detail to be disaggregated and revised, to match the gaps of the model. The data represents the current level of technology and targets high-volume manufacturing to the largest extent possible. Also, flows crossing the system boundary have a recommended link to Ecoinvent data, or a request for an attentive selection of input data, depending on the user’s object of study. A distinction was made between the regular and an extended system boundary, wherein the processing of some smaller subparts was accounted for through proposals of ready-made Ecoinvent activities for production efforts. Results and discussion: An extensive new dataset representing electrical machine manufacturing is presented, and, together with the estimation of motor mass and configuration of article part I, it forms a comprehensive scalable LCI model of a typical automotive electric traction motor. New production data includes a complete motor factory, electrical steel production, and the fabrication of a neodymium-dysprosium-iron-boron (Nd(Dy)FeB) magnet. In addition, smaller, new datasets cover the composition of silicon steel, the making of electrolytic iron, enameling of copper wire, and die casting of aluminum. Conclusions: Successful data generation required “data building” from multiple sources and access to expert support. Transparent, well-explained, and disaggregated data records were found to be crucial for LCA data validation and usefulness

Review of High-Temperature Recovery of Rare Earth (Nd/Dy) from Magnet Waste

Rare-earth metals, particularly neodymium, dysprosium, and praseodymium are becoming increasingly important in the transition to a green economy due to their essential role in permanent magnet applications such as in electric motors and generators. With the increasingly limited rare-earth supply and complexity of processing Nd, Dy, and Pr from primary ores, recycling of rare-earth based magnets has become a necessary option to manage supply and demand. Depending on the form of the starting material (sludge or scrap), there are different routes that can be used to recover neodymium from secondary sources, ranging from hydrometallurgical (based on its primary production process), electrochemical to pyrometallurgical. Pyrometallurgical routes provide solution in cases where water is scarce and generation of waste is to be limited. This paper presents a systematic review of previous studies on the high-temperature (pyrometallurgical) recovery of rare earths from magnets. The features and conditions at which the recycling processes had been studied are mapped and evaluated technically. The review also highlights the reaction mechanisms, behaviors of the rare-earth elements, and the formation of intermediate compounds in high-temperature recycling processes. Recommendations for further scientific research to enable the development of recovery of the rare-earth and magnet recycling are also presented